Tag Archive for: Stalicla SA

Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01

Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia.

12 October 2022